Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma. | Leuk Lymphoma;54(10): 2219-25, 2013 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma.

Zou, Yandun; Sheng, Zhixin; Niu, Shaona; Wang, Huijuan; Yu, Jinming; Xu, Jingbo.

Affiliation

Zou Y; Internal Medicine, GuangDong Women and Children Hospital , GuangZhou , China.

Leuk Lymphoma ; 54(10): 2219-25, 2013 Oct.

Article in En | MEDLINE | ID: mdl-23394458

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Country of publication: